Worldwide Point of Care Diagnostics (POCD) Market Insights: Industry Size, Growth Analysis and Forecast

Report ID : 1352498 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Point Of Care Diagnostics (POCD) Market is categorized based on Product Type (Blood Glucose Monitoring Devices, Cardiovascular Testing Devices, Infectious Disease Testing Devices, Pregnancy and Fertility Testing Devices, Cancer Biomarkers Testing Devices) and End-User (Hospitals, Clinics, Home Care Settings, Diagnostic Laboratories, Pharmacies) and Technology (Lateral Flow Assays, Molecular Diagnostics, Microfluidics, Biosensors, Immunoassays) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

In 2023, the Point Of Care Diagnostics (POCD) Market size was $25 billion and is projected to grow to $50 billion by 2033, registering a CAGR of 7.5% from 2024 to 2033. This report includes multiple segments and provides an analysis of key trends and factors playing a substantial role in the market.

The market for Point of Care Diagnostics (POCD) is growing significantly as healthcare systems around the world focus on immediate and accurate diagnoses. This is particularly true in cases where rapid results can critically impact patient care. POCD includes various diagnostic tests done either on the patient or close to the patient’s vicinity, which enhances the speed of clinical decisions and overall healthcare delivery. Due to technology improvements and increasing attention to personalized medicine, the POCD market is booming and will continue to do so over the next few years.

The evolution of healthcare gives room for POCD to create a paradigm shift in diagnostic processes, thus enabling timely and suited care. POCD incorporates a range of testing instruments like blood glucose monitors, infectious disease, and cardiac marker testing, which all aim for enhanced patient management and treatment outcomes. In addition, a steady rise in chronic disease cases, coupled with an increase in the elderly population, drives the demand for point of care diagnostics, marking POCD's importance in contemporary medical practice.

The Point of Care Diagnostics market is currently at an intersection of innovation and technology as well as the need for improved patient care services. The POCD market Is highly likely to change for the better in the years to come due to rapid diagnostic capabilities and it’s value being recognized by the healthcare ecosystem stakeholders.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, BD (Becton, Dickinson and Company), Thermo Fisher Scientific, Danaher Corporation, Cepheid, Alere Inc., Hologic Inc., Quidel Corporation, Grifols S.A.
SEGMENTS COVERED	By Product Type - Blood Glucose Monitoring Devices, Cardiovascular Testing Devices, Infectious Disease Testing Devices, Pregnancy and Fertility Testing Devices, Cancer Biomarkers Testing Devices By End-User - Hospitals, Clinics, Home Care Settings, Diagnostic Laboratories, Pharmacies By Technology - Lateral Flow Assays, Molecular Diagnostics, Microfluidics, Biosensors, Immunoassays By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Point Of Care Diagnostics (POCD) Market Dynamics

The Point Of Care Diagnostics (POCD) Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Point Of Care Diagnostics (POCD) Market

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• BD (Becton
• Dickinson and Company)
• Thermo Fisher Scientific
• Danaher Corporation
• Cepheid
• Alere Inc.
• Hologic Inc.
• Quidel Corporation
• Grifols S.A.

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved